The corporate law firm Herbst Kinsky has again advised MIRACOR Medical Systems GmbH in course of a further milestone; this time on a series C financing round totalling EUR 7 mio. The financing was executed by Peppermint VenturePartners, who invested via Peppermint CBF-1 Fonds (Berlin) together with the existing investors aws Gründerfonds, BioMed, Earlybird, Delta and SHS.

MIRACOR Medical Systems GmbH is an in 2008 established Austrian medical device company dedicat-ed to improve clinical outcome of patients with impaired cardiac function. Miracor’s PiCSO® Impulse System aims to improve outcome of patients with acute myocardial infarction by improving myocardial perfusion during percutaneous coronary intervention (PCI). “This additional investment enables us to accelerate our plans to start first clinical activities in the US”, commented Werner Braun, PhD, Chairman of the Board of Miracor.

“Miracor stands for the companies we have accompanied from their very beginning in the sense of a long-term cooperation. Therefore we are particularly proud that a further financing partner is committed to the idea and products of Mircaor”, says Philipp Kinsky, partner at Herbst Kinsky.

Herbst Kinsky´s team was led by Philipp Kinsky supported by Carl Walderdorff.